首页|期刊导航|Intelligent Oncology|AI-driven network biology identifies SRC as a therapeutic target in metastatic pancreatic adenocarcinoma

AI-driven network biology identifies SRC as a therapeutic target in metastatic pancreatic adenocarcinoma

Ayla Zhang Jake Y.Chen

Intelligent Oncology2025，Vol.1Issue(3)：P.233-243,11.

Intelligent Oncology2025，Vol.1Issue(3)：P.233-243,11.DOI:10.1016/j.intonc.2025.06.004

AI-driven network biology identifies SRC as a therapeutic target in metastatic pancreatic adenocarcinoma

Ayla Zhang ¹Jake Y.Chen¹

作者信息

1. AlphaMind Club,LLC,Birmingham AL 35244,USA Systems Pharmacology AI Research Center,School of Medicine,The University of Alabama at Birmingham,Birmingham AL 35233,USA
折叠

摘要

关键词

Pancreatic adenocarcinoma/SRC kinase/ChatGPT-4o evaluation framework/Bioinformatics/Oncology drug development

分类

医药卫生

引用本文复制引用

Ayla Zhang,Jake Y.Chen..AI-driven network biology identifies SRC as a therapeutic target in metastatic pancreatic adenocarcinoma[J].Intelligent Oncology,2025,1(3):P.233-243,11.

基金项目

supported by the National Institute of Health Center grant awards(U54TR001005)to Dr.Jake Y.Chen,in which he serves as a co-investigator,a research start-up fund provided by the University of Alabama at Birmingham(UAB)to Dr.Chen and the UAB Systems Pharmacology AI Research Center grant to Dr.Chen. （U54TR001005）

Intelligent Oncology

ISSN：2950-2616

访问量0

下载量0

段落导航